Cargando…

Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer

BACKGROUND: Epithelial ovarian cancer (EOC) is morphologically heterogeneous being classified as serous, endometrioid, clear cell, or mucinous. Molecular genetic analysis has suggested a role for tumor suppressor genes located at chromosome 3p in serous EOC pathogenesis. Our objective was to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoffou, Paule Héléna, Edjekouane, Lydia, Meunier, Liliane, Tremblay, André, Provencher, Diane Michèle, Mes-Masson, Anne-Marie, Carmona, Euridice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112150/
https://www.ncbi.nlm.nih.gov/pubmed/21695196
http://dx.doi.org/10.1371/journal.pone.0020705
_version_ 1782205709162643456
author Yoffou, Paule Héléna
Edjekouane, Lydia
Meunier, Liliane
Tremblay, André
Provencher, Diane Michèle
Mes-Masson, Anne-Marie
Carmona, Euridice
author_facet Yoffou, Paule Héléna
Edjekouane, Lydia
Meunier, Liliane
Tremblay, André
Provencher, Diane Michèle
Mes-Masson, Anne-Marie
Carmona, Euridice
author_sort Yoffou, Paule Héléna
collection PubMed
description BACKGROUND: Epithelial ovarian cancer (EOC) is morphologically heterogeneous being classified as serous, endometrioid, clear cell, or mucinous. Molecular genetic analysis has suggested a role for tumor suppressor genes located at chromosome 3p in serous EOC pathogenesis. Our objective was to evaluate the expression of HYAL1, located at chromosome 3p21.3, in these EOC subtypes, and to investigate its correlation with the expression of steroid hormone receptors. METHODOLOGY/PRINCIPAL FINDINGS: We determined the mRNA expression of HYAL1, estrogen receptor (ER)-α, ERβ and progesterone receptor (PR) in EOC tumor samples and cell lines using quantitative RT-PCR. We also examined the expression of these genes in a publicly available microarray dataset. HYAL-1 enzyme activity was measured in EOC cell lines and in plasma samples from patients. We found that HYAL1 mRNA expression was elevated in clear cell and mucinous EOC tissue samples, but not in serous and endometrioid samples, normal ovaries or benign tumors. Similar results were obtained by two different techniques and with tissue sample cohorts from two independent institutions. Concordantly, HYAL1 mRNA levels and enzymatic activity were elevated only in EOC cell lines derived from clear cell and mucinous subtypes. We also showed that HYAL1 mRNA was inversely correlated to that of ERα specifically in clear cell and mucinous EOCs. Additionally, ectopic expression of ERα in a clear cell EOC cell line (ER- and PR-negative) induced 50% reduction of HYAL1 mRNA expression, supporting a role of ERα in HYAL1 gene regulation. Significantly, HYAL-1 activity was also high in the plasma of patients with these EOC subtypes. CONCLUSIONS/SIGNIFICANCE: This is the first report showing high HYAL-1 levels in EOC and demonstrating HYAL1 gene repression by ERα. Our results identify Hyaluronidase-1 as a potential target/biomarker for clear cell and mucinous EOCs and especially in tumors with low ERα levels.
format Online
Article
Text
id pubmed-3112150
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31121502011-06-21 Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer Yoffou, Paule Héléna Edjekouane, Lydia Meunier, Liliane Tremblay, André Provencher, Diane Michèle Mes-Masson, Anne-Marie Carmona, Euridice PLoS One Research Article BACKGROUND: Epithelial ovarian cancer (EOC) is morphologically heterogeneous being classified as serous, endometrioid, clear cell, or mucinous. Molecular genetic analysis has suggested a role for tumor suppressor genes located at chromosome 3p in serous EOC pathogenesis. Our objective was to evaluate the expression of HYAL1, located at chromosome 3p21.3, in these EOC subtypes, and to investigate its correlation with the expression of steroid hormone receptors. METHODOLOGY/PRINCIPAL FINDINGS: We determined the mRNA expression of HYAL1, estrogen receptor (ER)-α, ERβ and progesterone receptor (PR) in EOC tumor samples and cell lines using quantitative RT-PCR. We also examined the expression of these genes in a publicly available microarray dataset. HYAL-1 enzyme activity was measured in EOC cell lines and in plasma samples from patients. We found that HYAL1 mRNA expression was elevated in clear cell and mucinous EOC tissue samples, but not in serous and endometrioid samples, normal ovaries or benign tumors. Similar results were obtained by two different techniques and with tissue sample cohorts from two independent institutions. Concordantly, HYAL1 mRNA levels and enzymatic activity were elevated only in EOC cell lines derived from clear cell and mucinous subtypes. We also showed that HYAL1 mRNA was inversely correlated to that of ERα specifically in clear cell and mucinous EOCs. Additionally, ectopic expression of ERα in a clear cell EOC cell line (ER- and PR-negative) induced 50% reduction of HYAL1 mRNA expression, supporting a role of ERα in HYAL1 gene regulation. Significantly, HYAL-1 activity was also high in the plasma of patients with these EOC subtypes. CONCLUSIONS/SIGNIFICANCE: This is the first report showing high HYAL-1 levels in EOC and demonstrating HYAL1 gene repression by ERα. Our results identify Hyaluronidase-1 as a potential target/biomarker for clear cell and mucinous EOCs and especially in tumors with low ERα levels. Public Library of Science 2011-06-10 /pmc/articles/PMC3112150/ /pubmed/21695196 http://dx.doi.org/10.1371/journal.pone.0020705 Text en Yoffou et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yoffou, Paule Héléna
Edjekouane, Lydia
Meunier, Liliane
Tremblay, André
Provencher, Diane Michèle
Mes-Masson, Anne-Marie
Carmona, Euridice
Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title_full Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title_fullStr Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title_full_unstemmed Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title_short Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
title_sort subtype specific elevated expression of hyaluronidase-1 (hyal-1) in epithelial ovarian cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112150/
https://www.ncbi.nlm.nih.gov/pubmed/21695196
http://dx.doi.org/10.1371/journal.pone.0020705
work_keys_str_mv AT yoffoupaulehelena subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT edjekouanelydia subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT meunierliliane subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT tremblayandre subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT provencherdianemichele subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT mesmassonannemarie subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer
AT carmonaeuridice subtypespecificelevatedexpressionofhyaluronidase1hyal1inepithelialovariancancer